Rotavirus Prophylaxis Market Penetration, Adoption, Lighting Technology, Refurbishment, Passenger Comfort And Forecast 2023-2032|Pfizer Inc., Johnson & Johnson, Merck & Co., Novartis AG, Sanofi SA

The Business Research Company’s Rotavirus Prophylaxis Global Market Report 2024 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Rotavirus Prophylaxis Global Market Report 2023 evaluates rotavirus prophylaxis market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=13045&type=smp

The global rotavirus prophylaxis market is expected to grow from $8.15 billion in 2023 to $9.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to vaccine access and equity, emerging rotavirus strains, r&d investments, public health preparedness.The rotavirus prophylaxis market size is expected to see strong growth in the next few years. It will grow to $13.24 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%.

The increasing vaccine courses are expected to propel the growth of the rotavirus prophylaxis market going forward. A vaccine course is a specific dose of vaccine that is meant to be given to a person to produce protection from a particular disease. The vaccine course dosage stimulates the immunological response, providing excellent protection against rotavirus infection. This increased immunity minimizes the risk of diseases and improves the vaccine’s overall efficacy. For instance, in January 2022, according to a report published by the United Nations International Children’s Emergency Fund (UNICEF), a US-based provider of humanitarian and developmental help to children, around 5.71 million courses of RV1-5 frozen rotavirus vaccine were produced 2022, with a projected increase to 9.31 million courses by 2028. Furthermore, 5.29 million courses of RV5-2 lyophilized rotavirus vaccines were manufactured in 2022, with a projected rise to 6.13 million courses by 2028. Therefore, the increasing number of vaccines will drive the rotavirus prophylaxis market.

Get More Information On The Rotavirus Prophylaxis Market Report:

https://www.thebusinessresearchcompany.com/report/rotavirus-prophylaxis-global-market-report

The rotavirus prophylaxis market segments in the report are:

1) By Treatment: Rotarix, Rotavac, Rotavin-M1, Oral Rehydration Fluid, Other Treatments

2) By Route of Administration: Oral, Parenteral, Other Route of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

The table of contents in TBRC’s rotavirus prophylaxis market report includes:

1. Executive Summary
2. Rotavirus Prophylaxis Market Characteristics
3. Rotavirus Prophylaxis Market Trends And Strategies
4. Rotavirus Prophylaxis Market – Macro Economic Scenario
5. Global Rotavirus Prophylaxis Market Size and Growth

.

.

.

31. Rotavirus Prophylaxis Market Other Major And Innovative Companies
32. Global Rotavirus Prophylaxis Market Competitive Benchmarking
33. Global Rotavirus Prophylaxis Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Rotavirus Prophylaxis Market
35. Rotavirus Prophylaxis Market Future Outlook and Potential Analysis

Top Major Players

• Pfizer Inc.
• Johnson & Johnson
• Merck & Co.
• Novartis AG
• Sanofi SA

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model